These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 18593321)

  • 1. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
    Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
    Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
    McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
    J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
    Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
    Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemangiosarcoma in cats: 53 cases (1992-2002).
    Johannes CM; Henry CJ; Turnquist SE; Hamilton TA; Smith AN; Chun R; Tyler JW
    J Am Vet Med Assoc; 2007 Dec; 231(12):1851-6. PubMed ID: 18081524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and doxorubicin in dogs with hemangiosarcoma.
    Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
    J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary rib tumors in 54 dogs.
    Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
    J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
    Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
    Finotello R; Stefanello D; Zini E; Marconato L
    Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
    Teske E; Rutteman GR; Kirpenstein J; Hirschberger J
    Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999).
    Hahn KA; Endicott MM; King GK; Harris-King FD
    J Am Vet Med Assoc; 2007 Sep; 231(5):742-5. PubMed ID: 17764436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).
    Rassnick KM; Goldkamp CE; Erb HN; Scrivani PV; Njaa BL; Gieger TL; Turek MM; McNiel EA; Proulx DR; Chun R; Mauldin GE; Phillips BS; Kristal O
    J Am Vet Med Assoc; 2006 Aug; 229(3):401-6. PubMed ID: 16881833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
    Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
    Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.